Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
EHA 2025 Congress
2025 ASCO Annual Meeting
2025 ASBrS Annual Meeting
ESTRO 2025
DDW 2025
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
Expert��������s Corner
Advertisement
Advertisement
Jul
05
Today In Oncology
Addition of Glofitamab to R-CHOP or Pola-R-CHP in Younger Patients With High-Risk LBCL
FDA Grants Accelerated Approval to Sunvozertinib for Metastatic NSCLC With EGFR Exon 20 Insertion Mutations
PPP2R1A Mutations Linked to Improved Immunotherapy Outcomes in Ovarian Clear Cell Carcinoma
Bevacizumab Plus Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer
Lean Body Mass–Based Oxaliplatin Dosing and Risk of Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer
View More
Advertisement
